Current Assets
Cash, Cash Equivalents, and Marketable Securities
UnitedHealth Group Cash, Cash Equivalents, and Marketable Securities increased by 4.0% to $50.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.9%, from $46.45B to $50.11B. Over 5 years (FY 2020 to FY 2025), Cash, Cash Equivalents, and Marketable Securities shows an upward trend with a 3.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2015
Last reportedQ1 2026May 5, 2026
Metric ID:
cash_equivalents_marketable_securities_totalHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $42.13B | $42.76B | $40.22B | $39.84B | $40B | $39.55B | $42.32B | $45.38B | $44.13B | $44.35B | $44.9B | $44.13B | $44.73B | $46.26B | $46.92B | $46.45B | $46.61B | $46.82B | $48.18B | $50.11B |
| QoQ Change | — | +1.5% | -5.9% | -0.9% | +0.4% | -1.1% | +7.0% | +7.2% | -2.8% | +0.5% | +1.2% | -1.7% | +1.4% | +3.4% | +1.4% | -1.0% | +0.3% | +0.5% | +2.9% | +4.0% |
| YoY Change | — | — | — | — | -5.0% | -7.5% | +5.2% | +13.9% | +10.3% | +12.1% | +6.1% | -2.8% | +1.4% | +4.3% | +4.5% | +5.2% | +4.2% | +1.2% | +2.7% | +7.9% |
Range$39.55B – $50.11B
CAGR+3.7%
Avg YoY Growth+4.0%
Median YoY Growth+4.4%
Current Streak4 quarters growth
Cash, Cash Equivalents, and Marketable Securities at Other Companies
Frequently Asked Questions
- What is UnitedHealth Group's cash, cash equivalents, and marketable securities?
- UnitedHealth Group (UNH) reported cash, cash equivalents, and marketable securities of $50.11B in Q1 2026.
- How has UnitedHealth Group's cash, cash equivalents, and marketable securities changed year-over-year?
- UnitedHealth Group's cash, cash equivalents, and marketable securities increased by 7.9% year-over-year, from $46.45B to $50.11B.
- What is the long-term trend for UnitedHealth Group's cash, cash equivalents, and marketable securities?
- Over 5 years (2020 to 2025), UnitedHealth Group's cash, cash equivalents, and marketable securities has grown at a 3.9% compound annual growth rate (CAGR), from $39.83B to $48.18B.